舒泰神：公司与辽宁奥克暂无研发方向的合作

Core Viewpoint - The company has confirmed that there is currently no collaborative research and development direction with Okai Pharmaceutical regarding polyethylene glycol drugs, despite Okai being a supplier of raw materials for the company's product Shutaqing [1] Group 1 - Investors inquired about potential collaboration on polyethylene glycol drug development with Okai Pharmaceutical [1] - The company clarified that Okai Pharmaceutical is a supplier for Shutaqing but there is no ongoing R&D collaboration [1]